Gefitinib Tablets

Gefitinib is a EGFR tyrosine kinase inhibitor supplied as tablets. It is used in standard clinical practice for EGFR-mutation-positive non-small cell lung cancer, as described in general pharmacological references.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.